| Excerpt | Reference |
|---|
| "Oesophageal varices are found in the submucosa of the lower oesophageal sphincter (L." | ( Miskowiak, J, 1978) |
| "Detection of oesophageal varices is important in the diagnosis of portal hypertension." | ( Davis, M; Laws, JW; Nunnerley, H; Waldram, R; Williams, R, 1977) |
| "Bleeding gastroesophageal varices is associated with a high morbidity and mortality." | ( Abdullah, T; Leong, YP; Meah, FA; Tay, SK; Zain, AR, 1992) |
| "Direct injection of gastric varices is difficult because of increased postsclerotherapy bleeding, but sclerosis of esophageal varices often leads to their obliteration by the caudad flow of sclerosant." | ( Fabry, TL; Goldberg, H, 1989) |
| "Bleeding from esophageal varices is a feared complication of liver cirrhosis with high mortality." | ( Miotti, T; Reichen, J, 1985) |
| "Oesophageal varices are the commonest cause of acute upper gastrointestinal bleeding in Egypt, due to the prevalence not only of schistosomiasis but also chronic hepatitis." | ( Sherif, SM; Yassin, YM, 1983) |
| "Bleeding from oesophageal varices is an uncommon but potentially fatal condition that often leads to expensive hospitalizations in intensive care or high-dependency units." | ( Bosanquet, N; Burroughs, AK; Greenslade, L; Matheson, LA; Matsaganis, M; McCormick, PA, 1995) |
| "Bleeding from gastric varices is an uncommon condition for which hemostatic control is difficult and ill defined." | ( Chung, SC; Leong, HT; Li, AK; Ng, EK, 1994) |
| "Small esophageal varices are difficult to inject intravariceally and complete eradication of varices may not be therapeutically necessary." | ( Agrawal, BK; Kumar, P; Singh, V; Suman, A, 1993) |
| "Bleeding from gastric varices is often a serious medical emergency." | ( Sarin, SK, 1997) |
| "Hemorrhage from esophageal varices is a life-threatening event in patients with liver cirrhosis." | ( Gross, M; Zoller, WG, 1996) |
| "Sclerotherapy of esophageal varices is a procedure which caries high risk of DIC and ARDS syndrome induced by intravenous administration of obliterative agent." | ( Meissner, AJ; Ratajczak, J; Rusiniak, K; Szczepanik, AB, 1997) |
| "Esophageal varices are treated by endoscopic ligation with or without sclerotherapy." | ( Hayashi, N; Mitsunaga, A; Murata, Y; Nakamura, S; Suzuki, S, 2001) |
| "Esophageal varices are a frequent complication among patients with liver cirrhosis." | ( Alvarez, R; Alvarez, V; Ciriza, C; Coto, E; Fuentes, D; González, P; Menéndez, LG; Rodrigo, L; Rodríguez, M, 2001) |
| "Though many gastric varices are treated endoscopically with n-butyl-2-cyanoacrylate, its behavior in varices is not known precisely." | ( Akamatsu, T; Kajiyama, M; Kawamura, Y; Matsumoto, A; Nakamura, N; Saegusa, H; Suga, T; Takei, M, 2002) |
| "bleeding from gastric varices is a life-threatening complication of portal hypertension." | ( Biswas, R; Chawla, Y; Dhiman, RK; Dilawari, JB; Sharma, TR; Taneja, S, 2002) |
| "If gastric varices are found at the index endoscopy the evidence at present is inadequate to be certain which is the best treatment, but both endoscopic therapy with cyanoacrylate or thrombin and transjugular intrahepatic portosystemic stent shunt (TIPSS) have been reported to be of benefit." | ( Ferguson, JW; Hayes, PC; Tripathi, D, 2003) |
| "Bleeding from gastroesophageal varices is a frequent and often deadly complication of cirrhosis." | ( Abraldes, JG; Bosch, J; Dell'Era, A, 2004) |
| "Esophageal varices are a commonly encountered complication of cirrhosis." | ( Gawrieh, S; Saeian, K, 2004) |
| "Bleeding gastric varices are increasingly being obliterated with the aid of endoscopic injection of n-butyl-cyanoacrylate (histoacryl) diluted with lipiodol." | ( Alexander, S; Korman, MG; Sievert, W, 2006) |
| "Ruptured gastroesophageal varices are the most severe and frequent causes of upper gastrointestinal bleeding in patients suffering from liver cirrhosis, accounting for 80% of all bleeding episodes." | ( Altorjay, I; Papp, M; Tornai, I; Udvardy, M; Vitális, Z, 2006) |
| "Gastric varices are a major cause of gastrointestinal bleeding in patients with portal hypertension." | ( Chen, K; Lin, X; Shi, B; Upadhyaya, M; Wu, Y; Wu, Z; Zhu, H, 2010) |
| "Gastroesophageal varices are the most common type of gastric varices." | ( Chang, CJ; Hou, MC; Lee, HS; Lee, SD; Liao, WC; Lin, HC; Su, CW, 2010) |
| "Bleeding from gastric varices is often severe and difficult to manage." | ( Chander Sharma, B; Kumar, A; Mishra, SR; Sarin, SK, 2010) |
| "Bleeding esophageal varices is the most serious complication of the portal hypertension, and the greater cause of dead (25% of the patients)." | ( Arnone, E; Geraci, G; Lo Nigro, C; Modica, G; Sciumè, C; Sciuto, A, 2011) |
| "Esophageal and gastric varices are associated with significant morbidity and mortality for cirrhotic patients." | ( Brayman, AA; Crum, LA; Hwang, JH; Starr, FL; Warren, C; Zhou, Y; Zia, J, 2011) |
| "Gastric varices are a major cause of gastrointestinal bleeding and death in patients with portal hypertension." | ( Eshraghian, A; Hamidpour, L; Moshfe, MJ; Taghavi, SA, 2012) |
| "Gastroesophageal varices are present in approximately 50% of patients with liver cirrhosis." | ( Abdo, M; El Askary, A; El Beshlawey, ML; Hassan, EM; Omran, DA, 2014) |
| "Esophageal varices are a dangerous complication of liver cirrhosis." | ( Dong, S; Hu, J; Hu, L; Jian, YC; Wang, J; Wang, L; Xiong, W; Yang, G, 2014) |
| "Bleeding from esophageal varices is a significant factor in mortality of patients with terminal liver cirrhosis." | ( Benedoto-Stojanov, D; Bjelaković, G; Brzački, V; Jović, J; Marković-Živković, B; Radisavljević, M; Radovanović-Dinić, B, 2017) |
| "However, esophagogastric varices are a poorly recognized outcome of oxaliplatin-based chemotherapy." | ( Ehira, T; Hattori, N; Ikeda, H; Itoh, F; Katayama, M; Koizumi, S; Matsumoto, N; Matsunaga, K; Matsuo, Y; Mizukami, T; Nakahara, K; Nakajima, TE; Nakano, H; Okuse, C; Otsubo, T; Sato, Y; Shigefuku, R; Suzuki, M; Suzuki, T; Tsuda, T; Watanabe, T; Yasuda, H, 2018) |
| "Bleeding due to esophageal varices is associated with high mortality and hospital costs." | ( Kaixin, L; Mei, Z; Mingshu, L; Ruyue, C; Yaru, H, 2022) |
| Excerpt | Reference |
|---|
| "Twenty patients bleeding from oesophageal varices, confirmed by endoscopy, were allocated into either treatment group (10 in each)." | ( Brearley, R; Harrison, ID; Sagar, S; Shields, R, 1979) |
| "The effect of sclerotherapy of esophageal varices on the gastroesophageal reflux was studied." | ( Chiba, T; Fukuzaki, H; Inatome, T; Ishido, S; Itoh, T; Kawanami, C; Kinoshita, Y; Kishi, K; Kitajima, N; Nishiyama, K, 1992) |
| "The relationship between recurrence of esophageal varices after endoscopic injection sclerotherapy (EIS) and changes of the blood pool of portosystemic collaterals was studied in 36 patients with liver cirrhosis." | ( Azuma, M; Fujita, S; Kashiwagi, T; Kimm, H; Koizumi, T; Matsuda, H; Mitsutani, N; Naito, M; Ohata, H; Okuno, A, 1992) |
| "Sclerotherapy of bleeding esophageal varices in liver cirrhotics is a common procedure, but little is known about the possible entry of sclerosants into the systemic circulation." | ( Brown-Castillo, J; Fujii, Y; Mammen, EF; Nakumura, R; Ozawa, T; Sugawa, C, 1991) |
| "During intravariceal sclerotherapy of esophageal varices with polidocanol in 32 patients with portal hypertension due to liver cirrhosis of various etiologies, endosonographic assessment of both esophageal and gastric intramural vessels was carried out in order to evaluate the usefulness of endosonography in the follow-up of the variceal status." | ( Gregor, M; Habermann, F; Riecken, EO; Zeitz, M; Ziegler, K; Zimmer, T, 1991) |
| "The results of esophageal varices treatment in two groups of patients are shown." | ( Jorge, AD; Milutin, C; Oliver, J, 1991) |
| "The effect of obliterating esophageal varices by endoscopic sclerotherapy on portal pressure was prospectively studied in 11 cirrhotic patients with variceal hemorrhage." | ( Korula, J; Ralls, P, 1991) |
| "No significant changes in the size of esophageal varices were observed after propranolol or placebo administration." | ( Bordas, JM; Bosch, J; Feu, F; Garcia-Pagán, JC; Rodés, J, 1991) |
| "It is concluded that obliteration of oesophageal varices by endoscopic sclerotherapy and propranolol may be more effective in the long-term control of variceal recurrence than treatment with sclerotherapy only." | ( Jensen, LS; Krarup, N, 1990) |
| "In injection sclerotherapy against esophageal varices, the damage of the endothelial cells of varices has been supposed to be most important for the formation of thrombi in the injected varices." | ( Orikasa, K, 1989) |
| "Fifty cirrhotic Japanese patients with oesophageal varices underwent sclerotherapy in a prospective randomized trial carried out to examine the effects of human thrombin given concomitantly with the sclerosant 5 per cent ethanolamine oleate." | ( Hashizume, M; Iso, Y; Iwanaga, T; Kitano, S; Sugimachi, K; Wada, H; Yamaga, H, 1989) |
| "Direct injection of gastric varices is difficult because of increased postsclerotherapy bleeding, but sclerosis of esophageal varices often leads to their obliteration by the caudad flow of sclerosant." | ( Fabry, TL; Goldberg, H, 1989) |
| "Sclerotherapy for esophageal varices was performed on six patients for a total of 16 injections." | ( Miyamae, T; Omoto, R; Sukigara, M, 1985) |
| "Forty-five cirrhotic patients with oesophageal varices underwent endoscopic injection sclerotherapy in a prospective randomized trial carried out to compare two sclerosing agents (5 per cent ethanolamine oleate and 2 per cent sodium tetradecyl sulphate (STD] with respect to safety, efficacy and complications." | ( Hashizume, M; Higashi, H; Iso, Y; Kitano, S; Sugimachi, K; Yamaga, H, 1988) |
| "Of 74 patients admitted for bleeding esophageal varices, 31 were treated with perivascular sclerotherapy (group I), and 43 with intravascular sclerotherapy (group II)." | ( Bourbon, P; Dentant, L; Rachail, M; Rousseau, E; Zarski, JP, 1988) |
| "Sclerotherapy of esophageal varices consists in obstruction of the varicosities." | ( Lebrec, D, 1986) |
| "43 patients with acute bleeding oesophageal varices were treated by means of endoscopic sclerotherapy using a modified fiber-endoscopic technic by either intravasal or combined intra- and paravasal injections." | ( Schwenke, E; Siedentopf, K, 1985) |
| "Results obtained in the control of oesophageal varix rupture haemorrhage by intravenous vasopressin perfusion or selective intraarterial administration are reported." | ( Belcastro, E; Ferraris, R; Fornaro, R; Parodi, G, 1985) |
| "A patient bleeding from oesophageal varices in whom injection sclerotherapy failed to control bleeding required peripheral vein vasopressin infusion for a total of five days." | ( Brearley, S; Dykes, PW; Hawker, PC; Keighley, MR, 1985) |
| "Due to the location of esophageal varices, paravasal sclerotherapy with all its alteration of the esophageal wall takes place in the lower third with its lower sphincter." | ( Friehs, G; Jüttner, FM; Klepp, G; Kohek, P; Rehak, P, 1985) |
| "Seventeen patients bleeding from oesophageal varices were treated by continuous infusion of vasopressin through a catheter inserted percutaneously and positioned in the superior mesenteric artery and in two other patients catheterization proved technically impossible." | ( Dawson, JL; Laws, JW; Murray-Lyon, IM; Nunnerley, HB; Pugh, RN; Williams, R, 1973) |
| "Therefore, treatment of esophageal varices by sclerosing procedures should only be done, if the esophageal wall has not been altered by mechanical therapeutic measures." | ( Hansen, H; Helpap, B, 1983) |
| "The development of bleeding esophagogastric varices and the methods used to treat this complication are all unsatisfactory either in the short or long term." | ( Bizer, LS, 1984) |
| "Two of 30 patients with esophageal varices had respiratory distress develop within 8-24 h of esophageal sclerotherapy." | ( Fairman, RP; Glauser, FL; Millen, JE; Monroe, P; Morrow, CF, 1983) |
| "Sclerotherapy for esophageal varices has recently gained wide acceptance in major medical centers for the control of bleeding esophageal varices." | ( Camara, DS; Cirbus, JJ; Perakos, PG, 1984) |
| "Three patients have been treated for gastric varices with the same method." | ( Jacobsen, CD; Rosseland, A; Stray, N, 1982) |
| "Of 31 cases of haemorrhage from oesophageal varices treated by sclerotherapy eight came to necropsy." | ( Cleary, BK; Evans, DM; Jones, DB; Smith, PM, 1982) |
| "Prophylactic sclerotherapy in esophageal varices with erosions and/or poor coagulation reserve of the liver can largely prevent an esophageal hemorrhage from varices, and prolongs the life of these chronically ill patients." | ( Paquet, KJ, 1982) |
| "Twenty dogs with large, bleeding gastric varices underwent endoscopic hemostasis with rubber band ligation, sclerotherapy, and cyanoacrylate injection." | ( Egan, J; Hirabayashi, K; Jensen, DM; Jutabha, R; Machicado, GA, 1995) |
| "Seventy-three patients with bleeding esophageal varices were treated by transesophageal injection of sclerosing agent through fiberoptic gastroscope (EIS)." | ( Cai, WY, 1993) |
| "A total of 197 patients with esophageal varices who had been treated by endoscopic injection sclerotherapy between 1985 and 1991 were observed for post-therapeutic bleeding from esophageal varices." | ( Kokawa, H; Kubara, K; Nakaoka, K; Okazaki, M; Shijo, H; Shirai, Z; Toriya, H, 1993) |
| "Sixteen cirrhotic patients with large oesophageal varices were studied by means of duplex-Doppler ultrasonography to determine variations in portal haemodynamics after oral administration of 0." | ( Cioni, G; Cristani, A; D'Alimonte, P; Romagnoli, R; Tincani, E; Turrini, F; Ventura, E, 1995) |
| "Recurrence of gastric varices was observed in three cases (10%), which were treated with repeated balloon-occluded retrograde transvenous obliteration." | ( Koito, K; Morita, K; Nagakawa, T; Namieno, T, 1996) |
| "Endoscopic treatment of esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone, is effective in controlling bleeding, and the complication rate is tolerable." | ( Altendorf-Hofmann, A; Bozkurt, T; Langer, M; Lux, G; Retterspitz, M; Stabenow-Lohbauer, U, 1997) |
| "Sclerotherapy of esophageal varices is a procedure which caries high risk of DIC and ARDS syndrome induced by intravenous administration of obliterative agent." | ( Meissner, AJ; Ratajczak, J; Rusiniak, K; Szczepanik, AB, 1997) |
| "The therapeutic schedule in bleeding esophageal varices is today established: emergency endoscopy with sclerotherapy or ligation combined with somatostatin and decreasing portal pressure drug followed by repetitive sclerotherapy or ligation." | ( Kantorová, I; Kozumplík, L; Ochmann, J; Svoboda, P, 1998) |
| "Endoscopic treatment for bleeding gastric varices is behind in hemostatic rate by 5% ethanolamine oleate as sclerosant." | ( Oho, K; Toyonaga, A, 1998) |
| "B-RTO is an effective therapy for gastric varices." | ( Dono, S; Hori, Y; Kiyosue, H; Matsumoto, S; Mori, H; Okahara, M; Onishi, R; Yamada, Y, 1999) |
| "The prevalence of paraesophageal varices was 86% in the ligation group compared with 51% in the sclerotherapy group (p = 0." | ( Cheng, JS; Chiang, HT; Huang, RL; Lai, KH; Lo, GH; Wang, SJ, 1999) |
| "This compound should be used to treat oesophageal varices by paravariceal injection in smaller doses than 5% ethanolamine oleate and 1% polidocanol." | ( Inoue, R; Kita, T; Nishida, R; Takimoto, Y, 1999) |
| "Fifty-one patients with cirrhosis and esophageal varices were randomly assigned to be treated by endoscopic scleroligation (n = 25) or endoscopic variceal ligation (n = 26)." | ( Onda, M; Tajiri, T; Toba, M; Umehara, M; Yamashita, K; Yoshida, H, 1999) |
| "Bleeding from thick or gastric varices was treated with cianoacrylate." | ( Estay, R; Mella, B; Ovalle, L; Sepúlveda, P; Soto, JR; Vargas, L, 1999) |
| "Bleeding came from thin esophageal varices in 23% of patients and endoscopic treatment stopped bleeding in 95% of them, from thick esophageal varices in 62% and endoscopic treatment was successful in 94% of these, and from gastric varices in 12% and treatment stopped bleeding in 87% of these (in 3% bleeding was considered subcardial)." | ( Estay, R; Mella, B; Ovalle, L; Sepúlveda, P; Soto, JR; Vargas, L, 1999) |
| "Treatment of bleeding esophageal varices with cianoacrylate or polidocanol is effective." | ( Estay, R; Mella, B; Ovalle, L; Sepúlveda, P; Soto, JR; Vargas, L, 1999) |
| "Five patients with esophageal varices (Child's A = 1, B = 2, C = 2) underwent dynamic EUS-guided sclerotherapy with color flow Doppler." | ( Alcocer, E; Catalano, MF; Geenen, JE; Hogan, WJ; Lahoti, S, 2000) |
| "Any associated nonbleeding esophageal varices were subjected to traditional sclerotherapy in combination with the Bucrylate treatment." | ( Borzellino, G; Catalano, F; Cordiano, C; Girlanda, R; Guglielmi, A; Kind, R; Leopardi, F; Lombardo, F; Pratticò, F; Rodella, L; Ruzzenente, A, 2000) |
| "Eradication of esophageal varices by repeated injection sclerotherapy and maintenance of eradication using continued surveillance endoscopy may reduce recurrent variceal bleeding and death from esophageal varices." | ( Bornman, PC; Goldberg, PA; Krige, JE; Terblanche, J, 2000) |
| "Endoscopic treatment of esophageal varices may accentuate portal hypertensive gastropathy." | ( Chen, TA; Cheng, JS; Chiang, HT; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Wang, EM, 2001) |
| "Though many gastric varices are treated endoscopically with n-butyl-2-cyanoacrylate, its behavior in varices is not known precisely." | ( Akamatsu, T; Kajiyama, M; Kawamura, Y; Matsumoto, A; Nakamura, N; Saegusa, H; Suga, T; Takei, M, 2002) |
| "Endotherapy of bleeding gastric varices is problematic." | ( Baron, TH; Burgart, LJ; Gostout, CJ; Leontovich, O; Nguyen, AJ; Rajan, E, 2002) |
| "Rebleeding from gastric varices was not observed in patients treated with complete success, whereas two patients treated partially rebled within 1 week of the treatment (rate of rebleeding, 9%)." | ( Aikata, H; Chayama, K; Imamura, M; Ito, K; Kamada, K; Kawakami, Y; Kitamoto, M; Kono, H; Kurihara, Y; Matsumoto, A; Nakanishi, T; Shirakawa, H, 2002) |
| "Treatment of bleeding gastric varices (GVs) is still controversial, mainly because of anecdotal studies or inclusion of patients with GVs located at different sites that have variable incidences of bleeding." | ( Gupta, R; Jain, AK; Jain, M; Sarin, SK, 2002) |
| "sclerotherapy of gastric varices with BC is a safe and an effective treatment for control of bleeding and eradication." | ( Biswas, R; Chawla, Y; Dhiman, RK; Dilawari, JB; Sharma, TR; Taneja, S, 2002) |
| "The endoscopic grade of esophageal varices in 4 of 9 patients worsened after treatment with B-RTO (p < 0." | ( Arakawa, T; Fujiwara, Y; Higuchi, K; Itani, A; Kuga, T; Nakamura, K; Okazaki, H; Shiba, M, 2002) |
| "Subjects were 134 patients with esophageal varices complicated by HCC and liver cirrhosis: 38 underwent emergent therapy for bleeding varices and 96 underwent prophylactic sclerotherapy." | ( Fujimoto, K; Hara, M; Iwakiri, R; Matsunaga, K; Oda, K; Ogusu, T; Sakata, H; Shimoda, R; Utsumi, H; Yamamoto, K, 2003) |
| "The prophylactic sclerotherapy for esophageal varices prolongs long-term survival of patients with liver cirrhosis and HCC, better than emergency therapy." | ( Fujimoto, K; Hara, M; Iwakiri, R; Matsunaga, K; Oda, K; Ogusu, T; Sakata, H; Shimoda, R; Utsumi, H; Yamamoto, K, 2003) |
| "Prophylactic sclerotherapy for esophageal varices might be more effective in prolonging longterm survival of patients complicated by liver cirrhosis in the absence of hepatocellular carcinoma, compared with emergency sclerotherapy." | ( Fujimoto, K; Iwakiri, R; Kikkawa, A; Matsunaga, K; Oda, K; Ogusu, T; Ootani, A; Ootani, H; Sakata, H; Shimoda, R; Tsunada, S; Watanabe, K, 2003) |
| "Fifty-six patients with gastric varices and liver cirrhosis were treated at Almeida Memorial Hospital from June 1997 to May 2002 using the combined procedure." | ( Arakaki, Y; Fujioka, T; Ishitobi, H; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Takahashi, K, 2003) |
| "Four patients with gastric varices without catheterizable draining veins through a systemic vein were treated with transportal intravariceal sclerotherapy with n-butyl-2-cyanoacrylate (NBCA)." | ( Hori, Y; Kiyosue, H; Matsumoto, S; Mori, H; Okahara, M; Okino, Y; Yamada, Y, 2004) |
| "Management of patients with bleeding oesophageal varices comprises of mainly diagnostic endoscopy, sclerotherapy and band ligation." | ( Chatterjee, S; Van Marck, E, 2004) |
| "Selective venography of the gastric varices and injection of the sclerosing agent, a mixture of 10% ethanolamine oleate and iopamidol, through the microcatheter system without occluding the collateral veins was accomplished in one treatment session in all patients." | ( Kokawa, A; Morimoto, M; Numata, K; Saito, T; Shirato, K; Sugimori, K; Tanaka, K; Tomita, N, 2005) |
| "Sixty patients with cirrhosis and oesophageal varices with no history but at high risk of bleeding were randomized to ligation treatment (30 patients) or propranolol (30 patients)." | ( Elefsiniotis, I; Galanis, P; Goulas, S; Liatsos, C; Mavrogiannis, C; Papanikolaou, IS; Psilopoulos, D; Sparos, L, 2005) |
| "Endoscopic treatment for bleeding esophageal varices was first described 65 years ago, but the technique was not widely adopted until the 1970s." | ( Stiegmann, GV, 2006) |
| "Management of continued bleeding from esophageal varices despite adequate injection sclerotherapy remains one of the medical and surgical dilemmas." | ( Al-Salamah, SM; Al-Wahabi, K; Galul, R; Hameed, AM; Khalid, K; Qazi, SA, 2006) |
| "Twenty-seven patients with bleeding gastric varices underwent endoscopic treatment with variceal ligation followed by sclerotherapy with N-butyl-2-cyanoacrylate from November 1995 to November 2000." | ( Eguchi, Y; Fujimoto, K; Iwakiri, R; Kudo, S; Miyazaki, K; Mizuguchi, M; Mizuta, T; Nojiri, J; Ogata, S; Sakata, H; Shimoda, R; Sugimoto, N; Tsunada, S; Watanabe, K, 2007) |
| "All patients had esophageal varices secondary to hepatitis B and had their varices eliminated through endoscopic sclerotherapy before neovascularization." | ( Cheng, LF; Gu, Y; Li, CZ; Wang, ZQ, 2009) |
| "Ten patients with gastric varices were treated with n-butyl-2-cyanoacrylate endoscopic injection under fluoroscopic guidance for the purpose of hemostasis or prevention of recurrent bleeding." | ( Aramayo, AL; Caetano, EM; Goldenberg, A; Herani Filho, B; Linhares, MM; Lopes-Filho, Gde J; Matone, J; Matos, D; Sakamoto, FI; Sato, NY, 2008) |
| "The patient was stabilized and the gastric varices were treated with n-butyl-2-cyanoacrylate (two injections, total 7." | ( Gopal, DV; Pfau, PR; Said, A; Spier, BJ; Taylor, AJ, 2009) |
| "Simultaneous endoscopic treatment for gastric varices bleeding and concomitant esophageal varices is a safe and effective procedure in combination with antibiotic prophylaxis for patients with cirrhosis." | ( Chang, CJ; Hou, MC; Lee, HS; Lee, SD; Liao, WC; Lin, HC; Su, CW, 2010) |
| "Patients with gastro-oesophageal varices type 2 (GOV2) with eradicated oesophageal varices or isolated gastric varices type 1 (IGV1) who had bled from gastric varices were randomised to cyanoacrylate injection (n=33) or beta-blocker treatment (n=34)." | ( Chander Sharma, B; Kumar, A; Mishra, SR; Sarin, SK, 2010) |
| "Cirrhotics with large gastroesophageal varices type 2 with eradicated esophageal varices or large isolated gastric varix type 1, who had never bled from gastric varix, were randomised to cyanoacrylate injection (Group I, n=30), beta-blockers (Group II, n=29) or no treatment (Group III, n=30)." | ( Kumar, A; Mishra, SR; Sarin, SK; Sharma, BC, 2011) |
| "We report five cases of gastric varices that were successfully treated with balloon-occluded retrograde transvenous obliteration of varices (BRTO) using Polidocanol foam as an alternative sclerosant to ethanolamine oleate." | ( Ali, F; Cavanagh, K; Clements, W; Kavnoudias, H; Kemp, W; Lyon, S; Roberts, S, 2012) |
| "Patients with oesophageal varices undergoing measurement of HVPG before and under propranolol treatment (80-160 mg/day) were included." | ( Ferlitsch, A; Heinisch, BB; Kramer, L; Payer, BA; Peck-Radosavljevic, M; Pinter, M; Reiberger, T; Schwabl, P; Trauner, M; Ulbrich, G, 2013) |
| "Prophylactic treatment for esophageal varices has been performed without adequate supporting evidence." | ( Higaki, T; Matsuoka, S; Mizuno, S; Moriyama, M; Nakamura, M; Takayama, T; Yamazaki, S, 2014) |
| "High-risk esophageal varices (huge F3 varices or intermediate F2 varices positive for red color signs) were treated prophylactically." | ( Higaki, T; Matsuoka, S; Mizuno, S; Moriyama, M; Nakamura, M; Takayama, T; Yamazaki, S, 2014) |
| "A 60-year-old woman with bleeding oesophageal varices was treated with terlipressin 2 mg every fourth hour." | ( Krag, A; Poulsen, A, 2013) |
| "Optimal endoscopic treatment of gastric varices is still not standardized nowadays." | ( Bauerfeind, P; Gubler, C, 2014) |
| "Active bleeding of gastric varices can be treated successfully without the necessity of gastric rinsing with EUS-guided injection of Histoacryl." | ( Bauerfeind, P; Gubler, C, 2014) |
| "Bleeding from gastric varices has high mortality rate, and obliteration using N-butyl-2-cyanoacrylate is the treatment of choice." | ( Cançado, ER; Levin, AS; Lopes, BC; Nicodemo, EL; Ninomiya, DA; Randi, BA, 2015) |
| "Treatment failure, complications, gastric varices obturation, and survival did not differ between the two groups." | ( Chen, J; Chen, SY; Cui, CX; Luo, TC; Ma, LL; Tseng, YJ; Wang, J; Zeng, XQ, 2017) |
| "Once gastroesophageal varices have developed, non-selective beta-blockers remain the cornerstone of therapy." | ( Berzigotti, A; Bosch, J; Brunner, F, 2017) |
| "Rupture of esophageal varices occurred in three patients and was treated successfully with band ligation." | ( Luo, X; Ma, H; Wang, X; Yang, L; Yu, J; Zhao, Y, 2018) |
| "However, esophagogastric varices are a poorly recognized outcome of oxaliplatin-based chemotherapy." | ( Ehira, T; Hattori, N; Ikeda, H; Itoh, F; Katayama, M; Koizumi, S; Matsumoto, N; Matsunaga, K; Matsuo, Y; Mizukami, T; Nakahara, K; Nakajima, TE; Nakano, H; Okuse, C; Otsubo, T; Sato, Y; Shigefuku, R; Suzuki, M; Suzuki, T; Tsuda, T; Watanabe, T; Yasuda, H, 2018) |
| "Like esophageal varices, cardiac varices are often treated with endoscopic variceal ligation (EVL)." | ( Hinoki, A; Honda, T; Imai, N; Ishigami, M; Ishizu, Y; Ito, T; Makita, S; Shirota, C; Sumida, W; Tainaka, T; Uchida, H; Yamamoto, K; Yokota, K; Yokoyama, S, 2023) |
| "Like esophageal varices, cardiac varices are often treated with endoscopic variceal ligation (EVL)." | ( Hinoki, A; Honda, T; Imai, N; Ishigami, M; Ishizu, Y; Ito, T; Makita, S; Shirota, C; Sumida, W; Tainaka, T; Uchida, H; Yamamoto, K; Yokota, K; Yokoyama, S, 2023) |
| "Embolization of gastric varices with cyanoacrylate glue is the treatment of choice for digestive bleeding due to rupture of gastric varices." | ( Badre, W; Bellabah, A; Cheikhna, FZ; Elgasmi, N; Elrhaoussi, FZ; Haddad, F; Hliwa, W; Tahiri, M, 2022) |